Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
43 studies found for:    Open Studies | "Helicobacter Infections"
Show Display Options
Rank Status Study
1 Unknown  Comparison of 7-Day and 14-Day Bismuth Based Quadruple Therapy for Secondary Helicobacter Pylori Eradication
Condition: Helicobacter Infection
Interventions: Drug: pantoprazole;   Drug: bismuth;   Drug: metronidazole;   Drug: tetracycline
2 Unknown  Standard Triple Therapy vs Sequential Therapy in Treatment of H Pylori Infection
Condition: Helicobacter Infection
Interventions: Drug: Standard Triple Therapy;   Drug: Sequential Therapy
3 Recruiting The Efficacy of the 7 Days Tailored Therapy as 2nd Rescue Therapy for Eradication of H. Pylori Infection
Condition: Helicobacter Infection
Interventions: Procedure: H. pylori culture and antimicrobial susceptibility testing;   Drug: 14 days empirical bismuth quadruple therapy (Proton pump inhibitor);   Drug: Metronidazole;   Drug: Tetracycline;   Drug: tripotassium dicitrate bismuthate;   Drug: 7 days tailored therapy Proton Pump Inhibitor;   Drug: Moxifloxacin;   Drug: Amoxicillin
4 Not yet recruiting Endofaster Test for Helicobacter Pylori Detection in Patients on Proton Pump Inhibitor Therapy
Condition: Helicobacter Infections
Interventions: Procedure: Gastroscopy;   Device: EndoFaster test;   Other: Clo test;   Other: Faecal Helicobacter pylori antigen
5 Recruiting Efficacy and Safety of Basic Triple Therapy Including Ilaprazole on the First Line Eradication Treatment of H.Pylori
Condition: Helicobacter Infections
Interventions: Drug: Noltec tab. 10mg;   Drug: Chongkundang Amoxicillin Cap. 500mg;   Drug: Cravit Tab. 500mg
6 Unknown  Second Line Therapy for the Cure of Helicobacter Pylori (H. Pylori) Infection
Conditions: Helicobacter Infections;   Gastritis;   Gastric Ulcer;   Duodenal Ulcer
Intervention: Drug: rabeprazole, amoxicillin, clarithromycin, metronidazole
7 Unknown  Treating H. Pylori in Parkinson's Patients With Motor Fluctuations
Conditions: Parkinson's Disease;   Helicobacter Infections;   Motor Fluctuations
Interventions: Drug: clartihromycin, amoxicillin, and omeprazole;   Drug: placebo
8 Unknown  Tailored Treatment of H. Pylori Infection Based Polymorphisms of CYP2C19 and 23S rRNA of H. Pylori
Conditions: Helicobacter Infections;   Gastritis;   Gastric Ulcer;   Duodenal Ulcer
Intervention: Drug: Lansoprazole, clarithromycin, amoxicillin
9 Unknown  Immediate Detection of Helicobacter Infection With a New Electrochemical System.
Condition: H. Pylori Infection
Interventions: Device: Electrochemical H. pylori detection method;   Device: IHC;   Device: C13-urea breath test;   Device: HUT
10 Recruiting Helicobacter Pylori Eradication Study in Parkinson's Disease
Conditions: Parkinson's Disease;   Helicobacter Pylori Infection
Interventions: Drug: Helicobacter pylori eradication therapy;   Drug: Placebo
11 Not yet recruiting The Impact of Addition of Curcumin for 10 Days Triple Therapy, on the Eradication Rate of Helicobacter Pylori Infection
Condition: Positivity for Helicobacter Pylori
Intervention: Dietary Supplement: Curcumin
12 Unknown  An Investigation of the Association Between Helicobacter Pylori Infection and Abdominal Pain in Cystic Fibrosis Patients
Conditions: Cystic Fibrosis;   Abdominal Pain;   Helicobacter Pylori Infection
Intervention:
13 Unknown  Efficacy and Safety of InSan Bamboo Salt on Improvement of Helicobacter Pylori Infection
Condition: Helicobacter Pylori Infection
Interventions: Dietary Supplement: InSan Bamboo Salt;   Dietary Supplement: Placebo
14 Recruiting Community-based Helicobacter Pylori Eradication
Condition: Helicobacter Pylori Infection
Intervention: Drug: Helicobacter pylori eradication
15 Recruiting Efficacy of 10-day Concomitant Regimen Versus High Dose Dual Therapy in Anti-Helicobacter Pylori Rescue Therapy
Condition: Helicobacter Pylori Infection
Interventions: Drug: high dose dual therapy;   Drug: concomitant therapy
16 Not yet recruiting The Diagnostic Validity of the Urea Breath Test
Condition: Helicobacter Pylori Infection
Intervention: Drug: Citric acid
17 Recruiting Comparison of 12-day Reverse Hybrid Therapy and 12-day Standard Triple Therapy for Helicobacter Pylori Infection
Condition: Helicobacter Pylori Infection
Interventions: Drug: Reverse hybrid therapy;   Drug: Standard triple therapy
18 Not yet recruiting Difference in H. Pylori Infection Rate of EGC Patients Before and After Endoscopic Resection
Condition: Early Gastric Cancer
Intervention:
19 Recruiting Helicobacter Pylori Eradication for Gastric Cancer Prevention in the General Population
Conditions: Gastric Cancer;   Helicobacter Pylori Infection
Intervention: Drug: 10-day bismuth-based quadruple therapy
20 Recruiting Multicentric Randomized Study of H. Pylori Eradication and Pepsinogen Testing for Prevention of Gastric Cancer Mortality
Conditions: Helicobacter Pylori Infections;   Atrophic Gastritis;   Gastric Cancer
Intervention: Drug: Triple therapy

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years